X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (67) 67
humans (60) 60
female (43) 43
infectious diseases (40) 40
pediatrics (38) 38
male (37) 37
immunology (34) 34
adult (22) 22
child (22) 22
children (22) 22
staphylococcus aureus (22) 22
infections (21) 21
adolescent (20) 20
abridged index medicus (17) 17
article (17) 17
influenza (17) 17
infant (16) 16
vaccines (16) 16
child, preschool (15) 15
influenza vaccines (15) 15
microbiology (15) 15
middle aged (15) 15
research (15) 15
colonization (13) 13
immunogenicity (13) 13
risk factors (13) 13
staphylococcus infections (13) 13
anti-bacterial agents - therapeutic use (12) 12
antigens (12) 12
safety (12) 12
staphylococcus aureus infections (12) 12
viruses (12) 12
young adult (12) 12
aged (11) 11
care and treatment (11) 11
epidemiology (11) 11
health aspects (11) 11
influenza, human - prevention & control (11) 11
methicillin-resistant staphylococcus aureus - isolation & purification (11) 11
nasal carriage (11) 11
prevalence (11) 11
staphylococcal infections - epidemiology (11) 11
vaccination (11) 11
antibodies (10) 10
disease (10) 10
double-blind method (10) 10
influenza vaccines - immunology (10) 10
adults (9) 9
avian influenza (9) 9
dosage and administration (9) 9
immune response (9) 9
methicillin-resistant staphylococcus aureus (9) 9
mrsa (9) 9
staphylococcal infections - microbiology (9) 9
united-states (9) 9
vaccine (9) 9
antibiotics (8) 8
influenza vaccines - administration & dosage (8) 8
management (8) 8
medicine, research & experimental (8) 8
pandemics (8) 8
antibodies, viral - blood (7) 7
bacteremia (7) 7
drug resistance (7) 7
rapid identification (7) 7
sepsis (7) 7
studies (7) 7
therapy (7) 7
allergy and immunology (6) 6
clinical trials (6) 6
community-acquired infections - microbiology (6) 6
diagnosis (6) 6
immunization (6) 6
infectious disease (6) 6
influenza, human - immunology (6) 6
methicillin (6) 6
methicillin resistance (6) 6
methicillin-resistant staphylococcus aureus - genetics (6) 6
mutation (6) 6
panton-valentine leukocidin (6) 6
prospective studies (6) 6
skin (6) 6
staphylococcal infections - drug therapy (6) 6
usage (6) 6
analysis (5) 5
animals (5) 5
avian flu (5) 5
carrier state - epidemiology (5) 5
carrier state - microbiology (5) 5
development and progression (5) 5
drug resistance in microorganisms (5) 5
genetic aspects (5) 5
hemagglutination (5) 5
hemagglutination inhibition (5) 5
hemagglutination inhibition tests (5) 5
hospitals (5) 5
influenza vaccines - adverse effects (5) 5
major and brief reports (5) 5
major articles and brief reports (5) 5
medicine, general & internal (5) 5
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 03/2015, Volume 372, Issue 12, pp. 1093 - 1103
Journal Article
The Journal of Infectious Diseases, ISSN 0022-1899, 9/2011, Volume 204, Issue 6, pp. 845 - 853
Journal Article
Vaccine, ISSN 0264-410X, 2016, Volume 35, Issue 2, pp. 375 - 384
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 06/2017, Volume 376, Issue 26, pp. 2545 - 2555
There are limited data on the role of antimicrobials in the treatment of skin abscesses. In this trial, clindamycin or trimethoprim–sulfamethoxazole was found... 
CLINICAL-PRACTICE GUIDELINES | SOFT-TISSUE INFECTIONS | MEDICINE, GENERAL & INTERNAL | AMERICA | MANAGEMENT | STAPHYLOCOCCUS-AUREUS INFECTIONS | ADULTS | RISK | DISEASES SOCIETY | TRIMETHOPRIM-SULFAMETHOXAZOLE | CHILDREN | Prospective Studies | Humans | Child, Preschool | Infant | Male | Skin Diseases, Bacterial - drug therapy | Anti-Bacterial Agents - therapeutic use | Clindamycin - adverse effects | Staphylococcal Skin Infections - drug therapy | Abscess - therapy | Adult | Female | Abscess - drug therapy | Anti-Bacterial Agents - adverse effects | Child | Double-Blind Method | Staphylococcus aureus - isolation & purification | Combined Modality Therapy | Trimethoprim, Sulfamethoxazole Drug Combination - adverse effects | Trimethoprim, Sulfamethoxazole Drug Combination - therapeutic use | Clindamycin - therapeutic use | Drainage | Skin Diseases, Bacterial - therapy | Adolescent | Intention to Treat Analysis | Methicillin-Resistant Staphylococcus aureus - isolation & purification | Care and treatment | Usage | Clindamycin | Patient outcomes | Surgery | Abscess | Staphylococcus aureus infections | Causes of | Dosage and administration | Drug therapy | Complications | Hypersensitivity | Clinical trials | Trimethoprim | Staphylococcus infections | Antimicrobial agents | Cellulitis | Drug resistance | Clinical outcomes | Methicillin | Studies | Trimethoprim-sulfamethoxazole | Sulfamethoxazole | Side effects | Motivation | Antibiotics | Abscesses | Skin | Children | Drug dosages
Journal Article
PLoS ONE, ISSN 1932-6203, 01/2017, Volume 12, Issue 1, p. e0167488
Background Vaccine development for influenza A/H5N1 is an important public health priority, but H5N1 vaccines are less immunogenic than seasonal influenza... 
IMMUNE-RESPONSE | PROTEIN ANTIGENS | VIRUS-INFECTION | INTERFERON-GAMMA | NK CELLS | IFN-GAMMA | MULTIDISCIPLINARY SCIENCES | ANTIGEN-PRESENTING CELLS | DIFFERENTIAL EXPRESSION ANALYSIS | MHC CLASS-II | INNATE IMMUNITY | Dendritic Cells - immunology | Humans | Middle Aged | Vaccination | Male | Monocytes - immunology | Antibodies, Viral - blood | Hemagglutination Inhibition Tests | Young Adult | Interleukin-6 - blood | Killer Cells, Natural - immunology | Adult | Female | Adjuvants, Immunologic - therapeutic use | Antibody Formation - immunology | Chemokine CXCL10 - blood | Double-Blind Method | Neutrophils - immunology | Antigen Presentation - genetics | Antigen Presentation - immunology | Systems Biology - methods | Influenza Vaccines - immunology | Influenza A Virus, H5N1 Subtype - immunology | Adolescent | Influenza, Human - prevention & control | Influenza, Human - immunology | Influenza vaccines | Avian influenza | Immune response | Analysis | Clinical trials | Genetic aspects | Interferon | Product development | B cells | Pediatrics | Aluminum | Physicians | Genes | Antigen processing | Viruses | Biology | Vaccines | Hemagglutination inhibition | Avian flu | Cell adhesion & migration | Interleukin 6 | Proteins | Randomization | Immunology | Lymphocytes | Cell cycle | IP-10 protein | Influenza A | Public health | Antigen presentation | Antigens | Lymphatic system | Cytokines | Dendritic cells | Research & development--R&D | Neutrophils | Leukocytes (neutrophilic) | T cell receptors | Gene expression | Medicine | Serum levels | Pathology | Signaling | Monocytes | Hemagglutination | Molecular modelling | Major histocompatibility complex | Immunogenicity | Influenza | Information processing | Adults | Research & development | R&D
Journal Article
PLoS ONE, ISSN 1932-6203, 06/2015, Volume 10, Issue 6, pp. e0127791 - e0127791
Journal Article
PloS one, ISSN 1932-6203, 2019, Volume 14, Issue 1, p. e0208356
Journal Article
Vaccine, ISSN 0264-410X, 2016, Volume 35, Issue 2, pp. 385 - 394
Journal Article
Journal Article